The effects of etafenone on the coronary and femoral circulations before and after adrenergic  -blockade in intact dogs.
D000318:Adrenergic beta-Agonists / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D004285:Dogs; D004336:Drug Antagonism; D005021:Ethylamines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D005260:Female; D005263:Femoral Artery / Q000187:drug effects*; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects; D010636:Phenols / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011427:Propiophenones / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects*; D014665:Vasodilator Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D000318:Adrenergic beta-Agonists; D005021:Ethylamines; D010636:Phenols; D011427:Propiophenones; D014665:Vasodilator Agents; D011433:Propranolol